Buprenorphine Hydrochloride Tablet
Product Images NDC 70518-4571

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Buprenorphine Hydrochloride (NDC 70518-4571). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mm1 (Buprenorphine 8mg 70518 4571 00)

Mm1 (Buprenorphine 8mg 70518 4571 00)
Buprenorphine Sublingual Tablet C-II, 8 mg strength, shown in a package label with quantity of 30 tablets per box. The label includes the NDC number 70518-4571-00 and indicates repackaging by RemedyRepack Inc. The label also includes storage instructions and a caution regarding federal law on drug transfer.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Label for buprenorphine hydrochloride sublingual tablet C-II, 8 mg strength. The label indicates a single tablet quantity and includes the NDC 70518-4571-01. It is repackaged by RemedyRepack Inc. and has storage instructions and a federal law caution regarding drug transfer. The label includes manufacturer information for PAI Pharma, Greenville, SC.*
FDA Label Image

Chemical Structure (Buprenorphine Hydrochloride 1)

Chemical Structure (Buprenorphine Hydrochloride 1)
Chemical structure diagram of buprenorphine hydrochloride, showing the molecular framework including functional groups and rings characteristic of the compound.*
FDA Label Image

Figure (Buprenorphine Hydrochloride 2)

Figure (Buprenorphine Hydrochloride 2)
An instructional illustration showing a person placing a tablet under the tongue. The open mouth is depicted with the tongue lifted to reveal the sublingual area where the tablet is positioned for administration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.